{"id": "article-73411_0", "title": "Sebaceous Hyperplasia -- Introduction", "content": "Sebaceous gland hyperplasia (SGH) is a benign and common condition of sebaceous glands.", "contents": "Sebaceous Hyperplasia -- Introduction. Sebaceous gland hyperplasia (SGH) is a benign and common condition of sebaceous glands."}
{"id": "article-73411_1", "title": "Sebaceous Hyperplasia -- Introduction", "content": "SGH affects adults of middle age or older, mainly males. It reportedly occurs in approximately 1% of the healthy population.\u00a0Sebaceous hyperplasia is not rare in newborns: an Iranian prospective cohort study reported that 43.7% of 1000 consecutive neonates examined had sebaceous hyperplasia; its appearance in that situation is transient and results from exposure to maternal hormones. [1] [2] It is uncommon during childhood and adolescence. [3] It has been described\u00a0in patients on chronic immunosuppressive therapy: reports of\u00a0the prevalence of SGH are as high as 10\u00a0to 16% in patients treated for long-period with cyclosporine A. [4] It has also been associated with genetic syndromes, in rare cases of Muir-Torre. [5] In general, sebaceous adenomas more strongly correlate with that syndrome, and sebaceous hyperplasias are common in patients without any underlying condition.", "contents": "Sebaceous Hyperplasia -- Introduction. SGH affects adults of middle age or older, mainly males. It reportedly occurs in approximately 1% of the healthy population.\u00a0Sebaceous hyperplasia is not rare in newborns: an Iranian prospective cohort study reported that 43.7% of 1000 consecutive neonates examined had sebaceous hyperplasia; its appearance in that situation is transient and results from exposure to maternal hormones. [1] [2] It is uncommon during childhood and adolescence. [3] It has been described\u00a0in patients on chronic immunosuppressive therapy: reports of\u00a0the prevalence of SGH are as high as 10\u00a0to 16% in patients treated for long-period with cyclosporine A. [4] It has also been associated with genetic syndromes, in rare cases of Muir-Torre. [5] In general, sebaceous adenomas more strongly correlate with that syndrome, and sebaceous hyperplasias are common in patients without any underlying condition."}
{"id": "article-73411_2", "title": "Sebaceous Hyperplasia -- Introduction", "content": "Sebaceous glands\u00a0have acini attached to an excretory duct; the production of sebum occurs inside the sebocyte, which accumulates lipids during its life cycle and then releases its content inside the principal excretory duct.\u00a0Sebaceous glands are androgen-sensitive,\u00a0so their activity differs according to circulating hormone levels and age. Sebaceous hyperplasia is composed of\u00a0normally-looking glands with an increased number of acini and mature sebocytes. The primary differential diagnoses include sebaceous adenoma, nevus sebaceus, lupus miliaris disseminatus faciei, and basal cell carcinoma.", "contents": "Sebaceous Hyperplasia -- Introduction. Sebaceous glands\u00a0have acini attached to an excretory duct; the production of sebum occurs inside the sebocyte, which accumulates lipids during its life cycle and then releases its content inside the principal excretory duct.\u00a0Sebaceous glands are androgen-sensitive,\u00a0so their activity differs according to circulating hormone levels and age. Sebaceous hyperplasia is composed of\u00a0normally-looking glands with an increased number of acini and mature sebocytes. The primary differential diagnoses include sebaceous adenoma, nevus sebaceus, lupus miliaris disseminatus faciei, and basal cell carcinoma."}
{"id": "article-73411_3", "title": "Sebaceous Hyperplasia -- Introduction", "content": "Treatment for sebaceous hyperplasia is usually not needed but can merit consideration when it becomes a cosmetic issue or if it is clinically confused with a more concerning lesion. Various treatments are available for this condition, including cryotherapy or cryosurgery, photodynamic therapy, laser treatment\u00a0(argon, carbon dioxide, or pulsed-dye laser), cauterization, or electrodesiccation shaving or excision, topical treatments\u00a0with chloroacetic or trichloroacetic acid, and systemic treatment with isotretinoin. [6] [7] [8] [9] [10]", "contents": "Sebaceous Hyperplasia -- Introduction. Treatment for sebaceous hyperplasia is usually not needed but can merit consideration when it becomes a cosmetic issue or if it is clinically confused with a more concerning lesion. Various treatments are available for this condition, including cryotherapy or cryosurgery, photodynamic therapy, laser treatment\u00a0(argon, carbon dioxide, or pulsed-dye laser), cauterization, or electrodesiccation shaving or excision, topical treatments\u00a0with chloroacetic or trichloroacetic acid, and systemic treatment with isotretinoin. [6] [7] [8] [9] [10]"}
{"id": "article-73411_4", "title": "Sebaceous Hyperplasia -- Issues of Concern", "content": "Sebaceous hyperplasia is a benign disease and generally does not require treatment. However, lesions can be unsightly and bothersome. The main concern is the clinical resemblance with other neoplastic lesions such as sebaceous adenoma and basal cell carcinoma.", "contents": "Sebaceous Hyperplasia -- Issues of Concern. Sebaceous hyperplasia is a benign disease and generally does not require treatment. However, lesions can be unsightly and bothersome. The main concern is the clinical resemblance with other neoplastic lesions such as sebaceous adenoma and basal cell carcinoma."}
{"id": "article-73411_5", "title": "Sebaceous Hyperplasia -- Causes", "content": "Sebaceous glands are highly sensitive to circulating androgens and have specific androgen-converting enzymes.\u00a0The pathogenesis surrounding SGH involves the changing hormonal environment that comes with increasing age.\u00a0In men, this often occurs in the eighth decade of life, while in women,\u00a0it happens shortly after menopause.\u00a0Decreasing levels of androgens lead to a decrease in sebocyte turnover, which activates a feedback stimulation of sebocyte proliferation within the gland and sebaceous hyperplasia. The effect is most pronounced over the face. The hormonal influence of insulin, TSH, and hydrocortisone also increase sebocyte proliferation.", "contents": "Sebaceous Hyperplasia -- Causes. Sebaceous glands are highly sensitive to circulating androgens and have specific androgen-converting enzymes.\u00a0The pathogenesis surrounding SGH involves the changing hormonal environment that comes with increasing age.\u00a0In men, this often occurs in the eighth decade of life, while in women,\u00a0it happens shortly after menopause.\u00a0Decreasing levels of androgens lead to a decrease in sebocyte turnover, which activates a feedback stimulation of sebocyte proliferation within the gland and sebaceous hyperplasia. The effect is most pronounced over the face. The hormonal influence of insulin, TSH, and hydrocortisone also increase sebocyte proliferation."}
{"id": "article-73411_6", "title": "Sebaceous Hyperplasia -- Causes", "content": "Sebaceous hyperplasia has been linked to long-term treatment with cyclosporine in the setting of organ transplantation, and specifically with the lipophilic cyclosporine A, due to a stimulatory effect on undifferentiated sebocytes. [11] [4] Levandoski reported a case of sebaceous hyperplasia in a renal transplant patient without prior exposure to cyclosporine, treated with the immunosuppressant tacrolimus. Sebaceous hyperplasia has been documented as a side effect of HIV antiretroviral treatment. [12]", "contents": "Sebaceous Hyperplasia -- Causes. Sebaceous hyperplasia has been linked to long-term treatment with cyclosporine in the setting of organ transplantation, and specifically with the lipophilic cyclosporine A, due to a stimulatory effect on undifferentiated sebocytes. [11] [4] Levandoski reported a case of sebaceous hyperplasia in a renal transplant patient without prior exposure to cyclosporine, treated with the immunosuppressant tacrolimus. Sebaceous hyperplasia has been documented as a side effect of HIV antiretroviral treatment. [12]"}
{"id": "article-73411_7", "title": "Sebaceous Hyperplasia -- Causes", "content": "Although SGH is common in the older population, presenile diffuse familial sebaceous hyperplasia (PDFSH) cases have been reported in the literature. [13] This form of sebaceous hyperplasia is linked to a genetic predisposition, has an earlier age of onset, and does not involve the periorificial regions. [14]", "contents": "Sebaceous Hyperplasia -- Causes. Although SGH is common in the older population, presenile diffuse familial sebaceous hyperplasia (PDFSH) cases have been reported in the literature. [13] This form of sebaceous hyperplasia is linked to a genetic predisposition, has an earlier age of onset, and does not involve the periorificial regions. [14]"}
{"id": "article-73411_8", "title": "Sebaceous Hyperplasia -- Anatomical Pathology", "content": "Sebaceous glands are skin appendages found in all parts of the body except on the soles and palms. The\u00a0areas where there is the highest concentration of sebaceous glands\u00a0are the face, back, upper arms, and chest.\u00a0Sebaceous glands\u00a0are composed of holocrine acini attached to a common excretory duct and a follicle, and together they comprise the pilosebaceous unit. Special types of sebaceous glands are not linked to the pilosebaceous unit and open directly towards the epithelial surface: in lips and buccal mucosa (Fordyce spots), glans penis or clitoris (Tyson glands), areolae (Montgomery's glands), and eyelids (Meibomian glands).", "contents": "Sebaceous Hyperplasia -- Anatomical Pathology. Sebaceous glands are skin appendages found in all parts of the body except on the soles and palms. The\u00a0areas where there is the highest concentration of sebaceous glands\u00a0are the face, back, upper arms, and chest.\u00a0Sebaceous glands\u00a0are composed of holocrine acini attached to a common excretory duct and a follicle, and together they comprise the pilosebaceous unit. Special types of sebaceous glands are not linked to the pilosebaceous unit and open directly towards the epithelial surface: in lips and buccal mucosa (Fordyce spots), glans penis or clitoris (Tyson glands), areolae (Montgomery's glands), and eyelids (Meibomian glands)."}
{"id": "article-73411_9", "title": "Sebaceous Hyperplasia -- Anatomical Pathology", "content": "The cells that form the sebaceous gland are called sebocytes and are organized in layers inside the acini. In the basal layer, there are reservoir cells (germinative cells) with basophilic nuclei: that's the mitotically active part of the gland.\u00a0As sebocytes differentiate, they accumulate increasing amounts of lipids inside the cytoplasm and migrate toward the central excretory duct. The mature sebocytes have vacuolated cytoplasms and small central nuclei with a scalloping effect due to compression by their lipid content. They are present near the central duct, and they disintegrate at the end of their life cycle, releasing their content (lipid and cellular debris) as sebum. The turnover time from sebocyte production to disintegration is approximately 1 month.", "contents": "Sebaceous Hyperplasia -- Anatomical Pathology. The cells that form the sebaceous gland are called sebocytes and are organized in layers inside the acini. In the basal layer, there are reservoir cells (germinative cells) with basophilic nuclei: that's the mitotically active part of the gland.\u00a0As sebocytes differentiate, they accumulate increasing amounts of lipids inside the cytoplasm and migrate toward the central excretory duct. The mature sebocytes have vacuolated cytoplasms and small central nuclei with a scalloping effect due to compression by their lipid content. They are present near the central duct, and they disintegrate at the end of their life cycle, releasing their content (lipid and cellular debris) as sebum. The turnover time from sebocyte production to disintegration is approximately 1 month."}
{"id": "article-73411_10", "title": "Sebaceous Hyperplasia -- Anatomical Pathology", "content": "Sebocytes arise in the fetus at 13 weeks from the\u00a0outer root sheath\u00a0of hair follicles.\u00a0In the fetus at term,\u00a0the effect of transplacental maternal androgens results in highly active sebaceous glands, responsible for the production of a protective layer called vernix caseosa.\u00a0Their activity and size regress in the newborn due to the withdrawal of maternal hormones. Sebaceous production is minimal throughout infancy and childhood. At puberty, as androgen production increases, sebaceous glands enlarge and become increasingly active, peaking during the third decade of life. In older adults, androgen levels decrease, and the sebum production slows down. [15] The decreasing levels of androgens result in smaller sebocytes with lower lipid content and larger nuclei; those sebocytes migrate slowly through the sebaceous gland. As migration of the sebocytes slows, the gland and the sebaceous duct become enlarged\u00a0with increased basal cells.", "contents": "Sebaceous Hyperplasia -- Anatomical Pathology. Sebocytes arise in the fetus at 13 weeks from the\u00a0outer root sheath\u00a0of hair follicles.\u00a0In the fetus at term,\u00a0the effect of transplacental maternal androgens results in highly active sebaceous glands, responsible for the production of a protective layer called vernix caseosa.\u00a0Their activity and size regress in the newborn due to the withdrawal of maternal hormones. Sebaceous production is minimal throughout infancy and childhood. At puberty, as androgen production increases, sebaceous glands enlarge and become increasingly active, peaking during the third decade of life. In older adults, androgen levels decrease, and the sebum production slows down. [15] The decreasing levels of androgens result in smaller sebocytes with lower lipid content and larger nuclei; those sebocytes migrate slowly through the sebaceous gland. As migration of the sebocytes slows, the gland and the sebaceous duct become enlarged\u00a0with increased basal cells."}
{"id": "article-73411_11", "title": "Sebaceous Hyperplasia -- Anatomical Pathology", "content": "In SGH, the sebaceous glands are normal in structure but increased in\u00a0number. The acini are attached to the central duct, which may become dilated. The presence of four or more sebaceous lobules\u00a0around a hair follicle has been suggested as\u00a0a diagnostic clue.\u00a0Sebaceous lobules show increasing numbers\u00a0and slightly\u00a0in size, are located in a more superficial position in the dermis, and have only two layers of germinative cells.", "contents": "Sebaceous Hyperplasia -- Anatomical Pathology. In SGH, the sebaceous glands are normal in structure but increased in\u00a0number. The acini are attached to the central duct, which may become dilated. The presence of four or more sebaceous lobules\u00a0around a hair follicle has been suggested as\u00a0a diagnostic clue.\u00a0Sebaceous lobules show increasing numbers\u00a0and slightly\u00a0in size, are located in a more superficial position in the dermis, and have only two layers of germinative cells."}
{"id": "article-73411_12", "title": "Sebaceous Hyperplasia -- Anatomical Pathology", "content": "The differential diagnosis primarily includes\u00a0sebaceous adenoma. Adenoma has an increased number of germinative cells (more than two layers) and the presence of immature eosinophilic sebocytes. There are architectural abnormalities, including the displacement of normal epithelial structures replaced by sebaceous elements. Mature sebocytes comprise more than 50% of the lesion.", "contents": "Sebaceous Hyperplasia -- Anatomical Pathology. The differential diagnosis primarily includes\u00a0sebaceous adenoma. Adenoma has an increased number of germinative cells (more than two layers) and the presence of immature eosinophilic sebocytes. There are architectural abnormalities, including the displacement of normal epithelial structures replaced by sebaceous elements. Mature sebocytes comprise more than 50% of the lesion."}
{"id": "article-73411_13", "title": "Sebaceous Hyperplasia -- Anatomical Pathology", "content": "Sebaceoma is another entity that can cause clinical confusion with sebaceous hyperplasia. It is a circumscribed and symmetrical lesion composed of solid nodules of immature sebocytes and germinative cells, duct-like spaces, and cystic changes.\u00a0The germinative cells form the main part of the lesion, representing more than\u00a050% of the cells. The overlying epidermis can appear keratotic, crusted, or ulcerated.", "contents": "Sebaceous Hyperplasia -- Anatomical Pathology. Sebaceoma is another entity that can cause clinical confusion with sebaceous hyperplasia. It is a circumscribed and symmetrical lesion composed of solid nodules of immature sebocytes and germinative cells, duct-like spaces, and cystic changes.\u00a0The germinative cells form the main part of the lesion, representing more than\u00a050% of the cells. The overlying epidermis can appear keratotic, crusted, or ulcerated."}
{"id": "article-73411_14", "title": "Sebaceous Hyperplasia -- Anatomical Pathology", "content": "Superficial epithelioma with sebaceous differentiation or reticulated acanthoma with sebaceous differentiation (RASD) is a rare entity initially proposed by Steffen and Ackerman. [16] [17] [18] There is epidermal acanthosis associated with clusters of sebocytes in a pattern that resembles reticulated seborrheic keratosis. The epidermis shows a\u00a0superficial reticulated proliferation of keratinocytes, and the sebocytes are mature with a thin layer of germinative cells\u00a0surrounding the lobules.", "contents": "Sebaceous Hyperplasia -- Anatomical Pathology. Superficial epithelioma with sebaceous differentiation or reticulated acanthoma with sebaceous differentiation (RASD) is a rare entity initially proposed by Steffen and Ackerman. [16] [17] [18] There is epidermal acanthosis associated with clusters of sebocytes in a pattern that resembles reticulated seborrheic keratosis. The epidermis shows a\u00a0superficial reticulated proliferation of keratinocytes, and the sebocytes are mature with a thin layer of germinative cells\u00a0surrounding the lobules."}
{"id": "article-73411_15", "title": "Sebaceous Hyperplasia -- Anatomical Pathology", "content": "Nevus sebaceus (spelling is correct without the \"o\" normally found in the word sebaceous) is a common hamartoma typically present at birth or appear during early childhood in the head and neck region. Histology shows\u00a0papillomatosis and hyperkeratosis, prominent sebaceous hyperplasia with the absence of hair follicles. Apocrine glands are often present. Sebaceous glands are abnormal in morphology and distribution: the localization is high\u00a0within the dermis, and the ducts communicate directly with the epidermal surface.", "contents": "Sebaceous Hyperplasia -- Anatomical Pathology. Nevus sebaceus (spelling is correct without the \"o\" normally found in the word sebaceous) is a common hamartoma typically present at birth or appear during early childhood in the head and neck region. Histology shows\u00a0papillomatosis and hyperkeratosis, prominent sebaceous hyperplasia with the absence of hair follicles. Apocrine glands are often present. Sebaceous glands are abnormal in morphology and distribution: the localization is high\u00a0within the dermis, and the ducts communicate directly with the epidermal surface."}
{"id": "article-73411_16", "title": "Sebaceous Hyperplasia -- Anatomical Pathology", "content": "Basal cell carcinoma (BCC) can be clinically similar to sebaceous hyperplasia, particularly in solitary lesions of sun-exposed areas of the face. BCC shows basaloid proliferation of neoplastic cells with peripheral palisading, tumor stromal-clefting, and extracellular mucin features not present\u00a0in sebaceous neoplasms.", "contents": "Sebaceous Hyperplasia -- Anatomical Pathology. Basal cell carcinoma (BCC) can be clinically similar to sebaceous hyperplasia, particularly in solitary lesions of sun-exposed areas of the face. BCC shows basaloid proliferation of neoplastic cells with peripheral palisading, tumor stromal-clefting, and extracellular mucin features not present\u00a0in sebaceous neoplasms."}
{"id": "article-73411_17", "title": "Sebaceous Hyperplasia -- Anatomical Pathology", "content": "Although sebaceous differentiation is evident in most cases of benign sebaceous neoplasms, special stains\u00a0may be required. Epithelial membrane antigen (EMA) expresses in the cytoplasm in up to 100% of cases. [15] Cytokeratin (CK) 7 and androgen receptor (AR) are also often expressed, but stains for these three antigens are not specific for sebaceous neoplasms because they can express in other adnexal tumors. Oil-Red-O (a lipid stain) can be performed, but requires a frozen section, and is not possible on the usual formalin-fixed, paraffin-embedded sections.\u00a0More specific stains are adipophilin\u00a0and Factor XIIIa (AC-1A1 clone). [19] [20]", "contents": "Sebaceous Hyperplasia -- Anatomical Pathology. Although sebaceous differentiation is evident in most cases of benign sebaceous neoplasms, special stains\u00a0may be required. Epithelial membrane antigen (EMA) expresses in the cytoplasm in up to 100% of cases. [15] Cytokeratin (CK) 7 and androgen receptor (AR) are also often expressed, but stains for these three antigens are not specific for sebaceous neoplasms because they can express in other adnexal tumors. Oil-Red-O (a lipid stain) can be performed, but requires a frozen section, and is not possible on the usual formalin-fixed, paraffin-embedded sections.\u00a0More specific stains are adipophilin\u00a0and Factor XIIIa (AC-1A1 clone). [19] [20]"}
{"id": "article-73411_18", "title": "Sebaceous Hyperplasia -- Anatomical Pathology", "content": "Given the association of sebaceous\u00a0adenomas (and only rarely sebaceous hyperplasias)\u00a0with Muir-Torre syndrome, stains to detect a clinically-undiagnosed microsatellite instability are options. Diagnosis of this syndrome could potentially help to help detect visceral neoplasms (especially colon cancer) at their pre-clinical stage, improving survival, but this is not something to consider with the usual example of sebaceous gland hyperplasia.", "contents": "Sebaceous Hyperplasia -- Anatomical Pathology. Given the association of sebaceous\u00a0adenomas (and only rarely sebaceous hyperplasias)\u00a0with Muir-Torre syndrome, stains to detect a clinically-undiagnosed microsatellite instability are options. Diagnosis of this syndrome could potentially help to help detect visceral neoplasms (especially colon cancer) at their pre-clinical stage, improving survival, but this is not something to consider with the usual example of sebaceous gland hyperplasia."}
{"id": "article-73411_19", "title": "Sebaceous Hyperplasia -- Clinical Pathology", "content": "No laboratory studies are necessary.  Sebaceous hyperplasia is diagnosed based on clinical examination or assisted by dermoscopy. A biopsy can be appropriate in differential diagnosis with basal cell carcinoma.\u00a0Histopathological examination of sebaceous hyperplasia lesions reveals enlarged glands with normal morphology. Inside each gland, mature sebaceous lobules connect to a dilated principal sebaceous duct.", "contents": "Sebaceous Hyperplasia -- Clinical Pathology. No laboratory studies are necessary.  Sebaceous hyperplasia is diagnosed based on clinical examination or assisted by dermoscopy. A biopsy can be appropriate in differential diagnosis with basal cell carcinoma.\u00a0Histopathological examination of sebaceous hyperplasia lesions reveals enlarged glands with normal morphology. Inside each gland, mature sebaceous lobules connect to a dilated principal sebaceous duct."}
{"id": "article-73411_20", "title": "Sebaceous Hyperplasia -- Biochemical and Genetic Pathology", "content": "Sebum production, together with sweat production, is highly androgen-sensitive; the activity and size of sebaceous glands are different according to age and circulating hormone levels. The number of sebaceous gland units remains approximately the same throughout life, but their metabolic rate differs during different life stages. Sebocytes contain androgen-metabolizing enzymes (5-alpha-reductase type I, 3-beta-hydroxysteroid dehydrogenase, 17-beta-hydroxysteroid dehydrogenase type II) which metabolize weak circulating androgens into potent androgens; a typical conversion is dehydroepiandrosterone-sulfate into dihydrotestosterone. The latter binding to androgen-specific receptors of the sebocytes increases their size and metabolic rate. Scalp and face are areas where the 5-alpha-reductase has the highest activity in conversion towards\u00a0testosterone and dihydrotestosterone, stimulating sebaceous gland proliferation. The opposite effect occurred for estrogens, which decrease sebaceous gland activity.", "contents": "Sebaceous Hyperplasia -- Biochemical and Genetic Pathology. Sebum production, together with sweat production, is highly androgen-sensitive; the activity and size of sebaceous glands are different according to age and circulating hormone levels. The number of sebaceous gland units remains approximately the same throughout life, but their metabolic rate differs during different life stages. Sebocytes contain androgen-metabolizing enzymes (5-alpha-reductase type I, 3-beta-hydroxysteroid dehydrogenase, 17-beta-hydroxysteroid dehydrogenase type II) which metabolize weak circulating androgens into potent androgens; a typical conversion is dehydroepiandrosterone-sulfate into dihydrotestosterone. The latter binding to androgen-specific receptors of the sebocytes increases their size and metabolic rate. Scalp and face are areas where the 5-alpha-reductase has the highest activity in conversion towards\u00a0testosterone and dihydrotestosterone, stimulating sebaceous gland proliferation. The opposite effect occurred for estrogens, which decrease sebaceous gland activity."}
{"id": "article-73411_21", "title": "Sebaceous Hyperplasia -- Biochemical and Genetic Pathology", "content": "Although SGH etiology has shown links to both intrinsic and extrinsic factors, the principal genetic changes remain unknown. Leopold et al. support the hypothesis that mutations in the EGFR-RASMAPK pathway play an important role in the pathogenesis of SGH. [21] Sebaceous hyperplasia occasionally occurs in areas of the body without UV exposure, including the buccal mucosa, vulva,\u00a0and areolae; otherwise,\u00a0UV rays are\u00a0considered as a cofactor. [22] [23] [24]", "contents": "Sebaceous Hyperplasia -- Biochemical and Genetic Pathology. Although SGH etiology has shown links to both intrinsic and extrinsic factors, the principal genetic changes remain unknown. Leopold et al. support the hypothesis that mutations in the EGFR-RASMAPK pathway play an important role in the pathogenesis of SGH. [21] Sebaceous hyperplasia occasionally occurs in areas of the body without UV exposure, including the buccal mucosa, vulva,\u00a0and areolae; otherwise,\u00a0UV rays are\u00a0considered as a cofactor. [22] [23] [24]"}
{"id": "article-73411_22", "title": "Sebaceous Hyperplasia -- Biochemical and Genetic Pathology", "content": "Muir\u2013Torre syndrome (MTS), described by Muir et al. in 1967 and Torre in 1968, is characterized by the presence of both sebaceous neoplasms and visceral malignancies. [25] The association with sebaceous hyperplasia is controversial, but research has demonstrated it in some cases; MTS should be a consideration in the appropriate clinical setting. [26] [27] [28] [29] [30] The transmission is typically autosomal dominant, so the identification of one patient can potentially aid in the identification of multiple cases in the entire family.\u00a0It is considered a variant of hereditary non-polyposis colorectal cancer (HNPCC) syndrome. [31]", "contents": "Sebaceous Hyperplasia -- Biochemical and Genetic Pathology. Muir\u2013Torre syndrome (MTS), described by Muir et al. in 1967 and Torre in 1968, is characterized by the presence of both sebaceous neoplasms and visceral malignancies. [25] The association with sebaceous hyperplasia is controversial, but research has demonstrated it in some cases; MTS should be a consideration in the appropriate clinical setting. [26] [27] [28] [29] [30] The transmission is typically autosomal dominant, so the identification of one patient can potentially aid in the identification of multiple cases in the entire family.\u00a0It is considered a variant of hereditary non-polyposis colorectal cancer (HNPCC) syndrome. [31]"}
{"id": "article-73411_23", "title": "Sebaceous Hyperplasia -- Biochemical and Genetic Pathology", "content": "The presence of germ-line mutations in DNA mismatch repair genes affects the proteins MLH1 or MSH2 and the microsatellite instability complex. About 35% of the cases are\u00a0microsatellite stable, some associated with biallelic inactivation of MYH. Loss of the mismatch repair complex can be demonstrated by immunohistochemistry against\u00a0MLH1, MSH2, MSH6, and PMS2. Loss of MSH2\u00a0and MSH6 staining is the most common pattern (63% of cases). Loss of the proteins MLH1 and PMS2 accounts for 19% of cases, while MSH6 loss accounts for the other 15% of cases.\u00a0It is crucial to\u00a0consider the cost-effectiveness of the test and its ethical implications. Also, identification of\u00a0somatic\u00a0mutation is more important than finding a germ-line mutation in individual lesions, because germ-line mutations can occur within lesions, without patients having MTS.", "contents": "Sebaceous Hyperplasia -- Biochemical and Genetic Pathology. The presence of germ-line mutations in DNA mismatch repair genes affects the proteins MLH1 or MSH2 and the microsatellite instability complex. About 35% of the cases are\u00a0microsatellite stable, some associated with biallelic inactivation of MYH. Loss of the mismatch repair complex can be demonstrated by immunohistochemistry against\u00a0MLH1, MSH2, MSH6, and PMS2. Loss of MSH2\u00a0and MSH6 staining is the most common pattern (63% of cases). Loss of the proteins MLH1 and PMS2 accounts for 19% of cases, while MSH6 loss accounts for the other 15% of cases.\u00a0It is crucial to\u00a0consider the cost-effectiveness of the test and its ethical implications. Also, identification of\u00a0somatic\u00a0mutation is more important than finding a germ-line mutation in individual lesions, because germ-line mutations can occur within lesions, without patients having MTS."}
{"id": "article-73411_24", "title": "Sebaceous Hyperplasia -- Morphology", "content": "SGH lesions can be isolated or multiple, present mainly on the face or less frequently on other parts of the body as soft yellow papules.\u00a0On physical examination, the papules show a central umbilication and branching vessels, especially if examined using a dermatoscope. A biopsy may be necessary to rule out basal cell carcinoma. [32] [11] However, papules of sebaceous hyperplasia are typically multiple and yellowish and are observable as small lobules with the aid of magnification dermoscopy. Rare variants of SGH include a linear\u00a0form,\u00a0zosteriform arrangement, a diffuse form, a giant form, a nevoid form,\u00a0and a familial form. [33] [34] [35]", "contents": "Sebaceous Hyperplasia -- Morphology. SGH lesions can be isolated or multiple, present mainly on the face or less frequently on other parts of the body as soft yellow papules.\u00a0On physical examination, the papules show a central umbilication and branching vessels, especially if examined using a dermatoscope. A biopsy may be necessary to rule out basal cell carcinoma. [32] [11] However, papules of sebaceous hyperplasia are typically multiple and yellowish and are observable as small lobules with the aid of magnification dermoscopy. Rare variants of SGH include a linear\u00a0form,\u00a0zosteriform arrangement, a diffuse form, a giant form, a nevoid form,\u00a0and a familial form. [33] [34] [35]"}
{"id": "article-73411_25", "title": "Sebaceous Hyperplasia -- Clinicopathologic Correlations", "content": "The classical clinical presentation of SGH is of a solitary nodule or multiple skin-colored or yellowish\u00a0papules localized\u00a0on the face (forehead, cheeks, chin) or in the upper trunk. The clini\u00adcal lesions display a central dell corresponding to the follicular infundibular ostium. These lesions are soft and vary in size from 2 to 9 mm.", "contents": "Sebaceous Hyperplasia -- Clinicopathologic Correlations. The classical clinical presentation of SGH is of a solitary nodule or multiple skin-colored or yellowish\u00a0papules localized\u00a0on the face (forehead, cheeks, chin) or in the upper trunk. The clini\u00adcal lesions display a central dell corresponding to the follicular infundibular ostium. These lesions are soft and vary in size from 2 to 9 mm."}
{"id": "article-73411_26", "title": "Sebaceous Hyperplasia -- Clinicopathologic Correlations", "content": "Dermoscopically, sebaceous hyperplasia reveals a pattern composed of aggregated white-yellowish nodules corresponding to hyperplastic sebaceous glands. The ostium of the gland is sometimes visible as a small crater or umbilication in the center of those yellowish nodules. [36] Surrounding the nodules, there is a vascular pattern visible with dermoscopy; the most common and specific is the so-called \"crown vessels\", which may extend toward the center without crossing it.\u00a0The dermoscopic findings significantly aid in the diagnosis. [37]", "contents": "Sebaceous Hyperplasia -- Clinicopathologic Correlations. Dermoscopically, sebaceous hyperplasia reveals a pattern composed of aggregated white-yellowish nodules corresponding to hyperplastic sebaceous glands. The ostium of the gland is sometimes visible as a small crater or umbilication in the center of those yellowish nodules. [36] Surrounding the nodules, there is a vascular pattern visible with dermoscopy; the most common and specific is the so-called \"crown vessels\", which may extend toward the center without crossing it.\u00a0The dermoscopic findings significantly aid in the diagnosis. [37]"}
{"id": "article-73411_27", "title": "Sebaceous Hyperplasia -- Clinical Significance", "content": "These lesions are benign but can create\u00a0a cosmetic concern. They are challenging to treat; the entire sebaceous unit must be eliminated to prevent a recurrence. The severity of SGH lesions has been classified\u00a0as limited if less than ten lesions are recognized, moderate (10\u00a0to 50 lesions), frequent (less than 100 lesions), and very frequent (more than 100 lesions). [38]", "contents": "Sebaceous Hyperplasia -- Clinical Significance. These lesions are benign but can create\u00a0a cosmetic concern. They are challenging to treat; the entire sebaceous unit must be eliminated to prevent a recurrence. The severity of SGH lesions has been classified\u00a0as limited if less than ten lesions are recognized, moderate (10\u00a0to 50 lesions), frequent (less than 100 lesions), and very frequent (more than 100 lesions). [38]"}
{"id": "article-73411_28", "title": "Sebaceous Hyperplasia -- Clinical Significance", "content": "Sebaceous hyperplasia is treatable with different techniques\u00a0with variable cosmetic results. The therapeutic outcomes have been categorized as optimal (if results in no scarring and no hypo- or hyperpigmentation), moderate (moderate scarring and/or hypo- or hyperpigmentation), and poor (scarring and/or hypo- or hyperpigmentation is prominent).", "contents": "Sebaceous Hyperplasia -- Clinical Significance. Sebaceous hyperplasia is treatable with different techniques\u00a0with variable cosmetic results. The therapeutic outcomes have been categorized as optimal (if results in no scarring and no hypo- or hyperpigmentation), moderate (moderate scarring and/or hypo- or hyperpigmentation), and poor (scarring and/or hypo- or hyperpigmentation is prominent)."}
{"id": "article-73411_29", "title": "Sebaceous Hyperplasia -- Clinical Significance", "content": "The main treatments are pharmaceutical agents like trichloroacetic acid (topic treatment) and isotretinoin (systemic). Physical treatments are cryotherapy, electrodesiccation, photodynamic and laser therapy, excision, shave, and curettage.\u00a0Cryotherapy, electrodesiccation, curettage, excision, and topical trichloroacetic acid can cause skin discoloration and scarring so that the cosmetic outcome can be unsatisfactory. Photodynamic therapy uses with the wavelength of\u00a01720\u00a0nm\u00a0that is said to be specific for the sebaceous gland unit; it provides minimal damage to the surrounding tissues but requires multiple sessions and special equipment. [39] The most appropriate lasers used to treat SGH are Argon and carbon dioxide (CO2). Oral isotretinoin is effective, but the treatment must continue for several months, and there are high relapse rates with discontinuation. It is not for use during pregnancy.", "contents": "Sebaceous Hyperplasia -- Clinical Significance. The main treatments are pharmaceutical agents like trichloroacetic acid (topic treatment) and isotretinoin (systemic). Physical treatments are cryotherapy, electrodesiccation, photodynamic and laser therapy, excision, shave, and curettage.\u00a0Cryotherapy, electrodesiccation, curettage, excision, and topical trichloroacetic acid can cause skin discoloration and scarring so that the cosmetic outcome can be unsatisfactory. Photodynamic therapy uses with the wavelength of\u00a01720\u00a0nm\u00a0that is said to be specific for the sebaceous gland unit; it provides minimal damage to the surrounding tissues but requires multiple sessions and special equipment. [39] The most appropriate lasers used to treat SGH are Argon and carbon dioxide (CO2). Oral isotretinoin is effective, but the treatment must continue for several months, and there are high relapse rates with discontinuation. It is not for use during pregnancy."}
{"id": "article-73411_30", "title": "Sebaceous Hyperplasia -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Sebaceous Hyperplasia -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}